Literature DB >> 7701115

Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this autoreactivity by CD4+/CD45RBlo T cells.

P J Morrissey1, K Charrier.   

Abstract

SCID mice injected with coisogenic CD4+/CD45RBhi lymph node T cells from normal donors develop a wasting disease that is due to hyperplasia of the intestinal epithelium. SCID mice injected with purified lymph node CD4+ T cells or CD4+/CD45RBlo T cells do not develop the disease. In addition, mixture of the CD4+/CD45RBlo T cells with equal numbers of CD4+/CD45RBhi T cells inhibits the development of disease. SCID mice that were reconstituted with CD45RBhi T cells with active disease were treated with oral antibiotics and this ameliorated the symptoms, suggesting a role of the gut bacterial flora in the development of disease. Attempts were made to accelerate or inhibit disease by chronically administering cytokines to the mice. Neither IL2 nor IL4 were effective in altering the course of disease development when given in doses known to be effective in other in vivo models. Thus, the regulation of the reactivity seen in these SCID mice may involve as yet unappreciated mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701115     DOI: 10.1016/s0923-2494(94)80200-9

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


  19 in total

Review 1.  Getting to the guts of immune regulation.

Authors:  Janine Bilsborough; Joanne L Viney
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

2.  Differential angiogenic regulation of experimental colitis.

Authors:  John H Chidlow; Will Langston; James J M Greer; Dmitry Ostanin; Maisoun Abdelbaqi; Jeffery Houghton; Annamalai Senthilkumar; Deepti Shukla; Andrew P Mazar; Matthew B Grisham; Christopher G Kevil
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

3.  Fyn promotes Th17 differentiation by regulating the kinetics of RORγt and Foxp3 expression.

Authors:  Aki Ueda; Liang Zhou; Paul L Stein
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

4.  Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis.

Authors:  Lillian Maggio-Price; Audrey Seamons; Helle Bielefeldt-Ohmann; Weiping Zeng; Thea Brabb; Carol Ware; Mingzu Lei; Robert M Hershberg
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

5.  Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.

Authors:  Li Zuo; Kai-Tao Yuan; Li Yu; Qing-Hong Meng; Peter Chee-Keung Chung; Ding-Hua Yang
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 6.  Induced and natural regulatory T cells in the development of inflammatory bowel disease.

Authors:  Christopher G Mayne; Calvin B Williams
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

Review 7.  The mdr1a-/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease.

Authors:  Jacque N Wilk; Janine Bilsborough; Joanne L Viney
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Lack of Effect of Murine Norovirus Infection on the CD4+ CD45RBhigh T-cell Adoptive Transfer Mouse Model of Inflammatory Bowel Disease.

Authors:  Charlie C Hsu; Karuna Patil; Audrey Seamons; Thea L Brabb; Piper M Treuting; Jisun Paik; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2020-01-14       Impact factor: 0.982

9.  Colitis-induced bone loss is gender dependent and associated with increased inflammation.

Authors:  Regina Irwin; Taehyung Lee; Vincent B Young; Narayanan Parameswaran; Laura R McCabe
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

10.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.